Stephen M. Hahn, MD, chief of radiation oncology and chief medical executive at MD Anderson Cancer Center in Houston, is being considered by the Trump administration to be the next commissioner of the FDA, according to numerous reports from outlets such as The Washington Post and The Wall Street Journal.
Stephen M. Hahn, MD, chief of radiation oncology and chief medical executive at MD Anderson Cancer Center in Houston, is being considered by the Trump administration to be the next commissioner of the FDA, according to numerous reports from outlets such as The Washington Post and The Wall Street Journal.